The use of corticosteroid therapy in refractory Kawasaki patients

Clinical Rheumatology

Volumn 23, Issue 1, 2004, Pages 11-13

  Al Mayouf, Sulaiman M ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Kawasaki disease; Methylprednisolone

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; DIPYRIDAMOLE; ETOPOSIDE; GLYCERYL TRINITRATE; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; WARFARIN;

ARTICLE; CASE REPORT; CHILDHOOD DISEASE; CORONARY ARTERY ANEURYSM; CORTICOSTEROID THERAPY; DRUG RESPONSE; FEMALE; GANGRENE; HUMAN; LONG TERM CARE; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PERICARDIAL EFFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT FAILURE;

CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; INJECTIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 1342305313     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0752-z     Document Type: Article

References (13)

1. Wright D, Newburger J, Baker A, Sundel R (1996) Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 128:146-149
2. Shinorhara M, Sone K, Tomomasa T, Morikawa A (1999) Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr 135:465-469
3. Dale R, Saleem M, Daw S, Dillon M (2000) Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr 137:723-726
4. Rauch A, Hurwitz E (1988) Centers for disease control case definition of Kawasaki syndrome. Pediatr Infect Dis J 142:441-444
5. Al-Eid W, Jefri A, Bahabri S, Al-Mayouf SM (2000) Haemophagocytosis in complicating Kawasaki disease. J Pediatr Hematol Oncol 17:323-329
6. Terai M, Shulman S (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131:888-893
7. Newburger J, Takahashi M, Beiser A et al. (1991) A single intravenous infusion of gamma globulin as compared with four in fusions in the treatment in Kawasaki disease. N Engl J Med 324:1633-1639
8. Chang J, Lin J, Peng C, Tsai C (1999) Kawasaki disease complicated by peripheral gangrene. Pediatr Cardiol 20:139-142
9. Sundel R, Burns J Baker A, Beiser A, Newburger J (1993) Gamma globulin re-treatment in Kawasaki disease. J Pediatr 123:657-659
10. Burns J, Capparelli E, Brown J, Newburger J, Glode M (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J 17:1144-1148
11. Kato H, Koike S, Yokoyome T (1979) Kawasaki disease: effect of treatment on coronary involvement. Pediatrics 63:175-179
12. Trumble T, Fitch R (1986) Kawasaki disease- A cause of vasculitis in children. J Pediatr Orthop 6:92-95
13. Ohga S, Ooshima A, Fukushige J, Ueda K (1995) Histocytic haemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state. Eur J Pediatr 154:539-541